Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 354

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 354
---
0 | % |     |         15,500,000 |     | 47.2 | % |

____________ (1)Shares of Profusa Common and Preferred stock at the respective exchange ratios based on no redemption versus maximum redemption. (2)Shares of Profusa vested stock options at the respective exchange ratios based on no redemption versus maximum redemption. •An estimated 1,588,914shares will be reserved for the potential future issuance of Profusa common stock upon the exercise of Profusa Options based on the conversion, as contemplated by the Merger Agreement, of all outstanding Profusa Options into options exercisable for shares of New Profusa Common Stock with the same terms except for the number of shares exercisable and the exercise price, each of which will be adjusted using the Exchange Ratio. This amount of reserved shares includes estimated 380,354shares related to net exercise of vested in -the-moneyoptions under a no redemption scenario and 380,354shares of net exercises of vested in -the-moneyoptions under the maximum redemption scenario as of the Closing, and which is included in Profusa’s equityholders right to receive an aggregate of 15,500,000shares of New Profusa Common Stock. •NorthView entered into a PIPE Subscription Agreement with the PIPE Investors for up to $22.22million Senior Secured Convertible Notes. See section entitled “ Summary of The Proxy Statement/Prospectus — PIPE Transaction” for a summary of the terms of the PIPE agreement with the PIPE Investors. •On November29, 2023, Profusa management, with shareholder consent, approved the issuance of Senior Convertible Promissory Notes for up to $3.0 million in aggregate principal amount and 12% interest (the “Note Purchase Agreement”), of which, management expects a total of $2.7 million will be borrowed. The proceeds are being used to fund its working capital needs. While the Note Purchase Agreement provides for the issuance of up to $3.0 million of senior secured promissory notes of Profusa, the total principal amount of notes issued under the Note Purchase Agreement was $2.7 million as of the December31, 2024 balance sheet date, and is currently $2.7 million total outstanding to date. On September27, 2024, Profusa management, with shareholder consent, amended the issuance of Senior Convertible Promissory Notes for up to $5.0million in aggregate principal amount and 12% interest (the “Note Purchase Agreement”), to allow capacity to